Evidence map›Paper›PMID 31675092›Full record

ArticleJournal of health politics, policy and law2020

The Grassroots of Grass: Cannabis Legalization Ballot Initiative Campaign Contributions and Outcomes, 2004-2016.

Daniel G Orenstein, Stanton A Glantz

Abstract read
In one paragraph

Article in Journal of health politics, policy and law, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Cannabis industry campaign expenditures in Colorado, 2005-2021.The International journal on drug policy · 2023
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel G OrensteinUniversity of California, San Francisco.
Stanton A GlantzUniversity of California, San Francisco.

Funding

Effect of Tobacco Advocacy at the State LevelR01DA043950 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI APOLLONIO, DOROTHY ELINOR · 2016 to 2020
$2.6M
NIDA NIH HHS R01 DA043950
6 · The paper itself

Abstract

contextAs of November 2018, medical cannabis was legal in 33 US states and recreational cannabis in 10, mostly enacted via ballot initiative.

methodsWe identified 32 cannabis legalization initiatives from 2004 to 2016 and obtained campaign contribution and state political and demographic data. After exploratory analyses of 15 potential independent variables, we quantified effects of 4 factors (initiative year, voter turnout, population born before 1946, advocate funding advantage) on voter support and likelihood of passage.

findingsA small number of campaign contributors dominated both sides of the issue, with little involvement by health advocates. Time and turnout, not money, were the factors most associated with electoral outcomes, consistent with increases in public opinion favoring cannabis legalization over time. Year, turnout, and population age were associated with voter support, while year, turnout, and advocate funding advantage were associated with likelihood of passage. When adjusting for an anomalous result, initiative year was the only variable that remained significantly associated with odds of passage, with a 1-year increase in initiative date associated with 2.02 times higher odds of passage (p < .01).

conclusionThese results underscore the importance of health advocate participation in developing cannabis legalization frameworks.

Indexed as

Gift GivingMedical MarijuanaPoliticsHumansMarijuana UsePolitical ActivismUnited StatesMedical Marijuanacampaign contributionsCannabis legalizationinitiativesmarijuanapublic policy

Identifiers

PMID31675092
PMCPMC6980940

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.